ClinicalTrials.Veeva

Menu

Respiratory Trends During Blood Transfusions in Newborns. (ARTE)

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Enrolling

Conditions

Blood Transfusion Associated Adverse Reactions
Blood Transfusion Complication
Respiratory Morbidity
Respiratory Complication

Treatments

Diagnostic Test: lung ultrasound

Study type

Interventional

Funder types

Other

Identifiers

NCT06443515
6438 (Other Identifier)

Details and patient eligibility

About

The prevalence of transfusion reactions is between 1 and 11% of transfusions. Most reactions are mild and do not pose a life-threatening risk to the patient. More serious problems may be the only manifestations that lead to suspicion of a transfusion reaction.

Most noninfectious transfusion reactions are immune-mediated. Two main types of reactions can be distinguished: TACO (transfusion associated cardiac overload, which is a cardiogenic pulmonary edema) and TRALI (transfusion related acute lung injury, non-cardiogenic pulmonary edema).

Although TRALI are diagnoses of exclusion, the presence of noncardiogenic pulmonary edema and respiratory problems in the vicinity of blood product transfusions should raise suspicion. Other signs of TRALI are hypotension and tachycardia, while in TACO arterial hypertension with positive water balance can be observed.

According to previous reports, the prevalence of transfusion reactions in the neonatal population is approximately 8%. Factors associated with these reactions are low birth weight and low gestational age. However, diagnostic criteria of respiratory transfusion reactions are not uniform across studies, and often the generic terms "acute lung injury" have been used.

Therefore, the primary objective of this study is to evaluate the respiratory trend during blood transfusions; secondary objectives are the study of risk factors for the development of respiratory worsening and the possible association with complications.

Enrollment

71 estimated patients

Sex

All

Ages

Under 1 month old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • admitted newborns requiring blood transfusions as per local practice and/or international guidelines

Exclusion criteria

  • newborns with major malformations
  • need for palliative care
  • lack of informed consent

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

71 participants in 1 patient group

study group
Other group
Description:
All infants undergoing blood transfusions will be enrolled in the study
Treatment:
Diagnostic Test: lung ultrasound

Trial contacts and locations

1

Loading...

Central trial contact

Stefano Nobile; Stefano Nobile, MD, PhD, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems